Education
About Us
Working with TipRanks
Follow Us
Certara (CERT)
NASDAQ:CERT
CERT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.41 - $19.87
Previous CloseN/A
Volume176.64K
Average Volume (3M)1.44M
Market Cap
$1.91B
Enterprise Value$1.96B
Total Cash (Recent Filing)$179.18M
Total Debt (Recent Filing)$14.17M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
May 01, 2025EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding161,017,780
10 Day Avg. Volume1,515,527
30 Day Avg. Volume1,444,244
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.95
Price to Cash Flow (P/CF)9.70
P/FCF Ratio11.00
Enterprise Value/Market Cap1.03
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.49
Enterprise Value/Ebitda42.77
Forecast
1Y Price Target
$14.92Price Target Upside25.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
---
Certara News
PremiumCompany Announcements
Certara Announces Leadership Change with Dr. Smith’s Departure
PremiumCompany Announcements
Certara’s Earnings Call Highlights Growth Amid Challenges
PremiumCompany Announcements
Certara, Inc. Reports Strong Q4 2024 Results---
Bulls Say, Bears Say
Bulls Say
R&D Investment And Cost ManagementCertara's initial 2025 guide underscores the continuation of positive dynamics such as prudent R&D investment and focus on cost-cutting.
Technology And InnovationMaximizing AI compatibility is another competitive edge cementing CERT as key biosimulation player to watch.
Bears Say
Regulatory Services PerformanceShares of CERT underperformed in 2024 largely due to lagging growth of its lower-margin regulatory services business.
---
Ownership Overview
2.26% Insiders
23.30% Mutual Funds
23.75% Other Institutional Investors
34.26% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CERT FAQ
What was Certara’s price range in the past 12 months?
Certara lowest stock price was $9.41 and its highest was $19.87 in the past 12 months.
What is Certara’s market cap?
Certara’s market cap is $1.91B.
When is Certara’s upcoming earnings report date?
Certara’s upcoming earnings report date is May 01, 2025 which is in 56 days.
How were Certara’s earnings last quarter?
Certara released its earnings results on Feb 26, 2025. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.123 by $0.027.
Is Certara overvalued?
According to Wall Street analysts Certara’s price is currently Undervalued.
Does Certara pay dividends?
Certara does not currently pay dividends.
What is Certara’s EPS estimate?
Certara’s EPS estimate is 0.11.
How many shares outstanding does Certara have?
Certara has 161,017,780 shares outstanding.
What happened to Certara’s price movement after its last earnings report?
Certara reported an EPS of $0.15 in its last earnings report, beating expectations of $0.123. Following the earnings report the stock price went up 0.568%.
Which hedge fund is a major shareholder of Certara?
Currently, no hedge funds are holding shares in CERT
---
Certara Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.92 (25.27% Upside)
$14.92 (25.27% Upside)
Blogger Sentiment
Bullish
CERT Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 414.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 4.3%
Last 30 Days ▲ 36.9%
Last 30 Days ▲ 36.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-37.23%
12-Months-Change
Fundamentals
Return on Equity
-1.14%
Trailing 12-Months
Asset Growth
0.77%
Trailing 12-Months
Company Description
Certara
Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides proven modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines.
---
CERT Company Deck
---
CERT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Certara's earnings call reflected a strong finish to 2024 with significant growth in software bookings and successful integration of strategic acquisitions. However, challenges such as cautious customer spending and elongated decision-making timelines dampened the overall outlook. The company's strategic investments in AI and software development are poised to drive future growth.Read More>---
CERT Stock 12 Month Forecast
Average Price Target
$14.92
▲(25.27% Upside)
Technical Analysis
Best Analysts Covering CERT
1 Year
1 Year Success Rate
3/12 ratings generated profit
1 Year Average Return
-8.62%
reiterated a buy rating 8 days ago
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -8.62% per trade.
---